Male infertility is a major issue worldwide and its causes remain unclear. Now, an international team of researchers led by Hiroki Shibuya at the ...

Earlier this year, researchers at CHOP and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder. KJ Muldoon ...

Comparing the genomes of snakes with distinct coloration patterns pinpointed the genetic variants that contribute to these ...

Bentham Science’s new release, Research Protocols for Ophthalmic Disease Mechanisms and Therapeutics: Glaucoma – Ocular Hypertension, compiles rigorously tested experimental methods aimed at advancing ...

KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell ...

As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...

Phage therapy is reshaping our understanding of how targeted viruses can reset the gut microbiome, offering a precise, ...

India opened the National One Health Mission Assembly 2025, stressing integrated human-animal-environment health, stronger ...

Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.

In a surprising discovery, a ‘sticky molecule’ that occurs naturally in our blood vessels could be both a culprit behind blood clots and organ failure during COVID and long COVID and the key to new ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 2:30 PM ESTCompany ParticipantsSteven Harr - President, ...